Management in the acute stage includes prompt fluid replacement to prevent the onset of acute tubular necrosis-. Many specific treatment modalities have been tried, generally without success. No doubt as more specific metabolic defects are discovered then more rational therapeutic options will follow. The development of specific genetic probes may allow for prenatal detection and for screening of carriers.
CASE HISTORY
A 51-year-old man presented with a short history of left renal colic, anaemia and deteriorating renal function (creatinine 505 mmollL, urea 18mmoIlL). He had been seen on two other occasions over the previous year with left renal colic and each time had successfully passed a stone. Radiological assessment suggested a radiolucent stone in the upper left ureter. Protein analysis of the urine and serum electrophoresis revealed Bence-Jones protein and a dense band of kappa light chains. Skeletal survey showed multiple lytic lesions in the humerus (Figure 1 ), skull and femora. Bone marrow trephine showed 30% plasma cells, confirming the clinical diagnosis of multiple myeloma.
The stone was removed by open ureterolithotomy and a concurrent renal biopsy revealed extensive tubular damage with cystic dilation due to cast formation typical of myeloma. His renal function improved after removal of the stone and initial chemotherapy. indicator". In this case the deposition of light chains within the tubules was also the cause of his chronic renal failure rather than just the obstructive uropathy.
Prevention of dehydration, hypercalcaemia and infection which can precipitate acute renal failure are important in myeloma patients '. This report highlights the need to consider the diagnosis of multiple myeloma in any patient who presents with unexplained radiolucent stones.
